Tissue-specific effects of bariatric surgery including mitochondrial function

Journal of Obesity

Volumn 2011, Issue , 2011, Pages

  Dankel, Simon N ^a   Staalesen, Vidar ^a   Bjørndal, Bodil ^a   Berge, Rolf K ^a   Mellgren, Gunnar ^a   Burri, Lena ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880967202     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2011/435245     Document Type: Article

References (90)

1. Buchwald H., Estok R., Fahrbach K., Banel D., Jensen M. D., Pories W. J., Bantle J. P., Sledge I., Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine 2009 122 3 248 e5 2-s2.0-61549094077 10.1016/j.amjmed.2008.09.041
2. Martins C., Strømmen M., Stavne O. A., Nossum R., Mårvik R., Kulseng B., Bariatric surgery versus lifestyle interventions for morbid obesity-changes in body weight, risk factors and comorbidities at 1year. Obesity Surgery. In press 2-s2.0-77950404131 10.1007/s11695-010-0131-1
3. Cannon C. P., Kumar A., Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options. Clinical Cornerstone 2009 9 4 55 71 2-s2.0-70349333812 10.1016/S1098-3597(09)80005-7
4. Pories W. J., MacDonald K. G., Morgan E. J., Sinha M. K., Dohm G. L., Swanson M. S., Barakat H. A., Khazanie P. G., Leggett-Frazier N., Long S. D., O'Brien K. F., Caro J. F., Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. American Journal of Clinical Nutrition 1992 55 2 582S 585S 2-s2.0-0026500361
5. Schauer P. R., Burguera B., Ikramuddin S., Cottam D., Gourash W., Hamad G., Eid G. M., Mattar S., Ramanathan R., Barinas-Mitchel E., Rao R. H., Kuller L., Kelley D., Saar M. G., Meguid M. A., Buchwald H., Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Annals of Surgery 2003 238 4 467 485 2-s2.0-10744222607 (Pubitemid 38176385)
6. Ahmed M. H., elziber@yahoo.com Byrne C. D., Bariatric surgery and renal function: a precarious balance between benefit and harm. Nephrology Dialysis Transplantation 2010 25 10 3142 3147 10.1093/ndt/gfq347
7. Shankar P., Boylan M., Sriram K., Micronutrient deficiencies after bariatric surgery. Nutrition 2010 26 11-12 1031 1037 2-s2.0-77950105587 10.1016/j.nut.2009.12.003
8. O'Brien P. E., McPhail T., Chaston T. B., Dixon J. B., Systematic review of medium-term weight loss after bariatric operations. Obesity Surgery 2006 16 8 1032 1040 2-s2.0-33747116101 10.1381/096089206778026316 (Pubitemid 44221269)
9. Hess D. S., Hess D. W., Oakley R. S., The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obesity Surgery 2005 15 3 408 416 2-s2.0-16244369781 (Pubitemid 40463610)
10. Cummings D. E., Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. International Journal of Obesity 2009 33 1 S33 S40 2-s2.0-64949131978 10.1038/ijo.2009.15
11. Fery F., D'Attellis N. P., Balasse E. O., Mechanisms of starvation diabetes: a study with double tracer and indirect calorimetry. American Journal of Physiology 1990 259 6 E770 E777 2-s2.0-0025633806
12. Wing R. R., Blair E. H., Bononi P., Marcus M. D., Watanabe R., Bergman R. N., Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 1994 17 1 30 36 2-s2.0-0028147295
13. Hughes T. A., Gwynne J. T., Switzer B. R., Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. American Journal of Medicine 1984 77 1 7 17 2-s2.0-0021266768 (Pubitemid 14084900)
14. Markovic T. P., Jenkins A. B., Campbell L. V., Furier S. M., Kraegen E. W., Chisholm D. J., The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care 1998 21 5 687 694 2-s2.0-0031767173 10.2337/diacare.21.5.687 (Pubitemid 28487056)
15. Wickremesekera K., Miller G., DeSilva Naotunne T., Knowles G., Stubbs R. S., Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obesity Surgery 2005 15 4 474 481 2-s2.0-18044381512 10.1381/0960892053723402 (Pubitemid 40605068)
16. Dixon J. B., O'Brien P. E., Playfair J., Chapman L., Schachter L. M., Skinner S., Proietto J., Bailey M., Anderson M., Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. Journal of the American Medical Association 2008 299 3 316 323 2-s2.0-38349136266 10.1001/jama.299.3.316 (Pubitemid 351159368)
17. Kashyap S. R., Daud S., Kelly K. R., Gastaldelli A., Win H., Brethauer S., Kirwan J. P., Schauer P. R., Acute effects of gastric bypass versus gastric restrictive surgery on β -cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. International Journal of Obesity 2010 34 3 462 471 2-s2.0-77949540795 10.1038/ijo.2009.254
18. Peterli R., Wölnerhanssen B., Peters T., Devaux N., Kern B., Christoffel-Courtin C., Drewe J., Von Flüe M., Beglinger C., Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Annals of Surgery 2009 250 2 234 241 2-s2.0-68949094297 10.1097/SLA.0b013e3181ae32e3
19. Guidone C., Manco M., Valera-Mora E., Iaconelli A., Gniuli D., Mari A., Nanni G., Castagneto M., Calvani M., Mingrone G., Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006 55 7 2025 2031 2-s2.0-33747038162 10.2337/db06-0068 (Pubitemid 44509976)
20. Salinari S., Guidone C., Bertuzzi A., Manco M., Asnaghi S., Mlngrone G., First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric Surgery. Diabetes Care 2009 32 3 375 380 2-s2.0-64749102777 10.2337/dc08-1314
21. Campos G. M., campos@surgery.wisc.edu Rabl C., Peeva S., Ciovica R., Rao M., Schwarz J.-M., Havel P., Schambelan M., Mulligan K., Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. Journal of Gastrointestinal Surgery 2009 14 1 15 23 10.1007/s11605-009- 1060-y
22. Lima M. M. O., endo.marcelolima@hotmail.com Pareja J. C., Alegre S. M., Acute effect of Roux-en-Y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. Journal of Clinical Endocrinology and Metabolism 2010 95 8 3871 3875 10.1210/jc.2010-0085
23. Laferrère B., Teixeira J., McGinty J., Tran H., Egger J. R., Colarusso A., Kovack B., Bawa B., Koshy N., Lee H., Yapp K., Olivan B., Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2008 93 7 2479 2485 2-s2.0-47549094687 10.1210/jc.2007-2851 (Pubitemid 352008510)
24. Service G. J., Thompson G. B., Service F. J., Andrews J. C., Collazo-Clavell M. L., Lloyd R. V., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. The New England Journal of Medicine 2005 353 3 249 254 2-s2.0-22344443114 10.1056/NEJMoa043690 (Pubitemid 41058324)
25. Carpenter T., Trautmann M. E., Baron A. D., abaron@amylin.com Kaiser A. M., akaiser@usc.edu John Service F., service.john@mayo.edu Thompson G. B., Lloyd R. V., Cummings D. E., Shannon M. H., Carlson M. J., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. The New England Journal of Medicine 2005 353 20 2192 2194 10.1056/NEJM200511173532017 (Pubitemid 41653115)
26. Troy S., Soty M., Ribeiro L., Laval L., Migrenne S., Fioramonti X., Pillot B., Fauveau V., Aubert R., Viollet B., Foretz M., Leclerc J., Duchampt A., Zitoun C., Thorens B., Magnan C., Mithieux G., Andreelli F., Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metabolism 2008 8 3 201 211 2-s2.0-50049119700 10.1016/j.cmet.2008.08.008
27. Laferrère B., Heshka S., Wang K., Khan Y., McGinty J., Teixeira J., Hart A. B., Olivan B., Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007 30 7 1709 1716 2-s2.0-34447132026 10.2337/dc06-1549 (Pubitemid 47036341)
28. Drucker D. J., The role of gut hormones in glucose homeostasis. Journal of Clinical Investigation 2007 117 1 24 32 2-s2.0-33845998516 10.1172/JCI30076 (Pubitemid 46048446)
29. Sandoval D., CNS GLP-1 regulation of peripheral glucose homeostasis. Physiology and Behavior 2008 94 5 670 674 2-s2.0-45449089337 10.1016/j.physbeh.2008.04.018 (Pubitemid 351850235)
30. Yamada C., Yamada Y., Tsukiyama K., Yamada K., Yamane S., Harada N., Miyawaki K., Seino Y., Inagaki N., Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes. Biochemical and Biophysical Research Communications 2007 364 1 175 180 2-s2.0-35348964675 10.1016/j.bbrc.2007.09.128 (Pubitemid 47599446)
31. Rubino F., Zizzari P., Tomasetto C., Bluet-Pajot M. T., Forgione A., Vix M., Grouselle D., Marescaux J., The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology 2005 146 4 1745 1751 2-s2.0-15444368751 10.1210/en.2004-1181 (Pubitemid 40396883)
32. Rubino F., Forgione A., Cummings D. E., Vix M., Gnuli D., Mingrone G., Castagneto M., Marescaux J., The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Annals of Surgery 2006 244 5 741 749 2-s2.0-33750331204 10.1097/01.sla.0000224726.61448.1b (Pubitemid 44629948)
33. Rodriguez-Grunert L., Galvao Neto M. P., Alamo M., Ramos A. C., Baez P. B., Tarnoff M., First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surgery for Obesity and Related Diseases 2008 4 1 55 59 2-s2.0-38049144259 10.1016/j.soard.2007.07.012
34. Kral J. G., Paez W., Wolfe B. M., Vagal nerve function in obesity: therapeutic implications. World Journal of Surgery 2009 33 10 1995 2006 2-s2.0-70349314685 10.1007/s00268-009-0138-8
35. Camilleri M., Toouli J., Herrera M. F., Kow L., Pantoja J. P., Billington C. J., Tweden K. S., Wilson R. R., Moody F. G., Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. Surgery for Obesity and Related Diseases 2009 5 2 224 229 2-s2.0-62549163020 10.1016/j.soard.2008.09.006
36. Berthoud H. R., Jeanrenaud B., Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats. Endocrinology 1979 105 1 146 151 2-s2.0-0018770622 (Pubitemid 9199137)
37. Pocai A., Obici S., Schwartz G. J., Rossetti L., A brain-liver circuit regulates glucose homeostasis. Cell Metabolism 2005 1 1 53 61 2-s2.0-16244383657 10.1016/j.cmet.2004.11.001 (Pubitemid 43960581)
38. Bikman B. T., Zheng D., Pories W. J., Chapman W., Pender J. R., Bowden R. C., Reed M. A., Cortright R. N., Tapscott E. B., Houmard J. A., Tanner C. J., Lee J., Dohm G. L., Mechanism for improved insulin sensitivity after gastric bypass surgery. Journal of Clinical Endocrinology and Metabolism 2008 93 12 4656 4663 2-s2.0-57349109343 10.1210/jc.2008-1030
39. Noakes M., Foster P. R., Keogh J. B., James A. P., Mamo J. C., Clifton P. M., Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk. Nutrition and Metabolism 2006 3, article 7 2-s2.0-33646123792 10.1186/1743-7075-3-7
40. Gill J. M. R., Cooper A. R., Physical activity and prevention of type 2 diabetes mellitus. Sports Medicine 2008 38 10 807 824 2-s2.0-52449112630 10.2165/00007256-200838100-00002
41. Poulos S. P., Hausman D. B., Hausman G. J., The development and endocrine functions of adipose tissue. Molecular and Cellular Endocrinology 2010 323 1 20 34 2-s2.0-77952888280 10.1016/j.mce.2009.12.011
42. Virtue S., Vidal-Puig A., It's not how fat you are, it's what you do with it that counts. PLoS Biology 2008 6 9, article e237 2-s2.0-55549130805 10.1371/journal.pbio.0060237
43. Bays H. E., González-Campoy J. M., Bray G. A., Kitabchi A. E., Bergman D. A., Schorr A. B., Rodbard H. W., Henry R. R., Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Review of Cardiovascular Therapy 2008 6 3 343 368 2-s2.0-41449114649 10.1586/14779072.6.3.343
44. Bays H. E., Laferrère B., Dixon J., Aronne L., González-Campoy J. M., Apovian C., Wolfe B. M., Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease? International Journal of Clinical Practice 2009 63 9 1285 1300 2-s2.0-69049096543 10.1111/j.1742-1241. 2009.02151.x
45. Kim S. J., Nian C., McIntosh C. H. S., Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes: a role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. Journal of Biological Chemistry 2007 282 12 8557 8567 2-s2.0-34247880256 10.1074/jbc.M609088200 (Pubitemid 47093503)
46. Irwin N., Flatt P. R., Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. Diabetologia 2009 52 9 1724 1731 2-s2.0-68449083816 10.1007/s00125-009-1422-8
47. Gregor M. F., Yang L., Fabbrini E., Mohammed B. S., Eagon J. C., Hotamisligil G. S., Klein S., Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 2009 58 3 693 700 2-s2.0-62749178966 10.2337/db08-1220
48. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J. L., Bouloumié A., Barbatelli G., Cinti S., Svensson P. A., Barsh G. S., Zucker J. D., Basdevant A., Langin D., Clément K., Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005 54 8 2277 2286 2-s2.0-23644450775 10.2337/diabetes.54.8.2277 (Pubitemid 41134253)
49. Dankel S. N., Fadnes D. J., Stavrum A. K., Stansberg C., Holdhus R., Hoang T., Veum V. L., Christensen B. J., V¥ V., Sagen J. V., Steen V. M., Mellgren G., Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PloS One 2010 5 6 e11033 10.1371/journal.pone.0011033
50. Henegar C., Tordjman J., Achard V., Lacasa D., Cremer I., Guerre-Millo M., Poitou C., Basdevant A., Stich V., Viguerie N., Langin D., Bedossa P., Zucker J. D., Clement K., Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biology 2008 9 1, article R14 2-s2.0-46249083328 10.1186/gb-2008-9-1-r14 (Pubitemid 351911933)
51. Dahlman I., Linder K., Nordström E. A., Andersson I., Lidén J., Verdich C., Sørensen T. I. A., Arner P., Changes in adipose tissue gene expression with energy-restricted diets in obese women. American Journal of Clinical Nutrition 2005 81 6 1275 1285 2-s2.0-21944438331 (Pubitemid 41710227)
52. Kolehmainen M., Salopuro T., Schwab U. S., Kekäläinen J., Kallio P., Laaksonen D. E., Pulkkinen L., Lindi V. I., Sivenius K., Mager U., Siitonen N., Niskanen L., Gylling H., Rauramaa R., Uusitupa M., Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. International Journal of Obesity 2008 32 2 292 303 2-s2.0-39449106720 10.1038/sj.ijo.0803718 (Pubitemid 351271783)
53. Taylor R., Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 2008 51 10 1781 1789 2-s2.0-51249107750 10.1007/s00125-008-1116-7
54. Leichman J. G., Wilson E. B., Scarborough T., Aguilar D., Miller C. C., Yu S., Algahim M. F., Reyes M., Moody F. G., Taegtmeyer H., Dramatic reversal of derangements in muscle metabolism and left ventricular function after bariatric surgery. American Journal of Medicine 2008 121 11 966 973 2-s2.0-54349098441 10.1016/j.amjmed.2008.06.033
55. Greco A. V., Mingrone G., Giancaterini A., Manco M., Morroni M., Cinti S., Granzotto M., Vettor R., Camastra S., Ferrannini E., Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002 51 1 144 151 2-s2.0-0036097562 (Pubitemid 34517991)
56. Adami G. F., Parodi R. C., Papadia F., Marinari G., Camerini G., Corvisieri R., Scopinaro N., Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion. Obesity Surgery 2005 15 9 1233 1237 2-s2.0-27644568522 10.1381/096089205774512483 (Pubitemid 41565116)
57. Johansson L., Roos M., Kullberg J., Weis J., Ahlström H., Sundbom M., Edén Engström B., Karlsson F. A., Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obesity Surgery 2008 18 10 1297 1304 2-s2.0-53849108133 10.1007/s11695-008-9484-0
58. Muoio D. M., Newgard C. B., Obesity-related derangements in metabolic regulation. Annual Review of Biochemistry 2006 75 367 401 2-s2.0-33746377553 10.1146/annurev.biochem.75.103004.142512 (Pubitemid 44118037)
59. Shalhub S., Parsee A., Gallagher S. F., Haines K. L., Willkomm C., Brantley S. G., Pinkas H., Saff-Koche L., Murr M. M., The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obesity Surgery 2004 14 1 54 59 2-s2.0-1642479937 10.1381/096089204772787293 (Pubitemid 38130716)
60. Adams L. A., Lymp J. F., St. Sauver J., Sanderson S. O., Lindor K. D., Feldstein A., Angulo P., angulohernandez.paul@mayo.edu The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005 129 1 113 121 10.1053/j.gastro.2005.04.014 (Pubitemid 41002048)
61. Verna E. C., Berk P. D., pb2158@columbia.edu Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Seminars in Liver Disease 2008 28 4 407 426 10.1055/s-0028-1091985
62. Moschen A. R., Molnar C., Wolf A. M., Weiss H., Graziadei I., Kaser S., Ebenbichler C. F., Stadlmann S., Moser P. L., Tilg H., Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. Journal of Hepatology 2009 51 4 765 777 2-s2.0-70249115442 10.1016/j.jhep.2009.06.016
63. Bell L. N., Temm C. J., Saxena R., Vuppalanchi R., Schauer P., Rabinovitz M., Krasinskas A., Chalasani N., Mattar S. G., Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content. Annals of Surgery 2010 251 6 1041 1048 2-s2.0-77953025796 10.1097/SLA.0b013e3181dbb572
64. Chavez-Tapia N. C., Tellez-Avila F. I., Barrientos-Gutierrez T., Mendez-Sanchez N., Lizardi-Cervera J., Uribe M., Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database of Systematic Reviews 2010 1 CD007340 2-s2.0-77649338357
65. Wellen K. E., Hotamisligil G. S., Inflammation, stress, and diabetes. Journal of Clinical Investigation 2005 115 5 1111 1119 2-s2.0-18244370762 10.1172/JCI200525102 (Pubitemid 40629025)
66. Boushel R., Gnaiger E., Schjerling P., Skovbro M., Kraunsøe R., Dela F., Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007 50 4 790 796 2-s2.0-33847611885 10.1007/s00125-007-0594-3 (Pubitemid 46355830)
67. Kelley D. E., He J., Menshikova E. V., Ritov V. B., Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002 51 10 2944 2950 2-s2.0-0036788293
68. Holloszy J. O., Skeletal muscle «mitochondrial deficiency» does not mediate insulin resistance. American Journal of Clinical Nutrition 2009 89 1 463S 466S 2-s2.0-58149379936 10.3945/ajcn.2008.26717C
69. Abdul-Ghani M. A., DeFronzo R. A., Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Current Diabetes Reports 2008 8 3 173 178 2-s2.0-52649149879 10.1007/s11892-008-0030-1
70. Szendroedi J., Roden M., Mitochondrial fitness and insulin sensitivity in humans. Diabetologia 2008 51 12 2155 2167 2-s2.0-55649095282 10.1007/s00125-008-1153-2
71. Pagel-Langenickel I., Bao J., Pang L., Sack M. N., The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocrine Reviews 2010 31 1 25 51 2-s2.0-76149131004 10.1210/er.2009-0003
72. Petersen K. F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D. L., DiPietro L., Cline G. W., Shulman G. I., Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003 300 5622 1140 1142 2-s2.0-0038025371 10.1126/science.1082889 (Pubitemid 36583097)
73. Mogensen M., Sahlin K., Fernström M., Glintborg D., Vind B. F., Beck-Nielsen H., Højlund K., Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007 56 6 1592 1599 2-s2.0-34249720640 10.2337/db06-0981 (Pubitemid 46842617)
74. Ritov V. B., Menshikova E. V., He J., Ferrell R. E., Goodpaster B. H., Kelley D. E., Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005 54 1 8 14 2-s2.0-12144275294 10.2337/diabetes.54.1.8 (Pubitemid 40105089)
75. Nair K. S., Bigelow M. L., Asmann Y. W., Chow L. S., Coenen-Schimke J. M., Klaus K. A., Guo Z. K., Sreekumar R., Irving B. A., Asian indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 2008 57 5 1166 1175 2-s2.0-43449097093 10.2337/db07-1556
76. de Feyter H. M., van den Broek N. M. A., Praet S. F. E., Nicolay K., van Loon L. J. C., Prompers J. J., Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. European Journal of Endocrinology 2008 158 5 643 653 2-s2.0-43149125385 10.1530/EJE-07-0756 (Pubitemid 351639601)
77. Shaham O., Wei RU., Wang T. J., Ricciardi C., Lewis G. D., Vasan R. S., Carr S. A., Thadhani R., Gerszten R. E., Mootha V. K., Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Molecular Systems Biology 2008 4, article 214 2-s2.0-49449083937 10.1038/msb.2008.50
78. Stump C. S., Short K. R., Bigelow M. L., Schimke J. M., Nair K. S., Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proceedings of the National Academy of Sciences of the United States of America 2003 100 13 7996 8001 2-s2.0-0038271638 10.1073/pnas.1332551100 (Pubitemid 36760083)
79. Mootha V. K., Lindgren C. M., Eriksson K. F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., Houstis N., Daly M. J., Patterson N., Mesirov J. P., Golub T. R., Tamayo P., Spiegelman B., Lander E. S., Hirschhorn J. N., Altshuler D., Groop L. C., PGC-1 α -responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 2003 34 3 267 273 2-s2.0-0038054341 10.1038/ng1180 (Pubitemid 36792858)
80. Patti M. E., Butte A. J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E. J., Goldfine A. B., Mun E., DeFronzo R., Finlayson J., Kahn C. R., Mandarino L. J., Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8466 8471 2-s2.0-0037477855 10.1073/pnas.1032913100 (Pubitemid 36842568)
81. Holloway G. P., Perry C. G. R., Thrush A. B., Heigenhauser G. J. F., Dyck D. J., Bonen A., Spriet L. L., PGC-1 α 's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1 α and PGC-1 β protein. American Journal of Physiology 2008 294 6 E1060 E1069 2-s2.0-47549098993 10.1152/ajpendo.00726.2007
82. Bach D., Naon D., Pich S., Soriano F. X., Vega N., Rieusset J., Laville M., Guillet C., Boirie Y., Wallberg-Henriksson H., Manco M., Calvani M., Castagneto M., Palacín M., Mingrone G., Zierath J. R., Vidal H., Zorzano A., Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor α and interleukin-6. Diabetes 2005 54 9 2685 2693 2-s2.0-24144462451 10.2337/diabetes.54.9.2685 (Pubitemid 41233591)
83. Bach D., Pich S., Soriano F. X., Vega N., Baumgartner B., Oriola J., Daugaard J. R., Lloberas J., Camps M., Zierath J. R., Rabasa-Lhoret R., Wallberg-Henriksson H., Laville M., Palacín M., Vidal H., Rivera F., Brand M., Zorzano A., Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism: a novel regulatory mechanism altered in obesity. Journal of Biological Chemistry 2003 278 19 17190 17197 2-s2.0-0037593949 10.1074/jbc.M212754200 (Pubitemid 36799599)
84. Chen K. H., Guo X., Ma D., Guo Y., Li Q., Yang D., Li P., Qiu X., Wen S., Xiao R. P., Tang J., Dysregulation of HSG triggers vascular proliferative disorders. Nature Cell Biology 2004 6 9 872 883 2-s2.0-4444270915 10.1038/ncb1161 (Pubitemid 39207252)
85. de Brito O. M., Scorrano L., Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008 456 7222 605 610 2-s2.0-57349100367 10.1038/nature07534
86. Hernández-Alvarez M. I., Chiellini C., Manco M., Naon D., Liesa M., Palacín M., Mingrone G., Zorzano A., Genes involved in mitochondrial biogenesis/function are induced in response to bilio-pancreatic diversion in morbidly obese individuals with normal glucose tolerance but not in type 2 diabetic patients. Diabetologia 2009 52 8 1618 1627 2-s2.0-67650649403 10.1007/s00125-009-1403-y
87. Dahlman I., Forsgren M., Sjögren A., Nordström E. A., Kaaman M., Näslund E., Attersand A., Arner P., Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor- α Diabetes 2006 55 6 1792 1799 2-s2.0-33748305621 10.2337/db05-1421 (Pubitemid 44324134)
88. Xu Y., Ohinata K., Meguid M. M., Marx W., Tada T., Chen C., Quinn R., Inui A., Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. Journal of Surgical Research 2002 107 1 56 63 2-s2.0-0036403294 (Pubitemid 35191813)
89. Kirchner H., Guijarro A., Meguid M. M., Is a model useful in exploring the catabolic mechanisms of weight loss after gastric bypass in humans? Current Opinion in Clinical Nutrition and Metabolic Care 2007 10 4 463 474 2-s2.0-34250662197 10.1097/MCO.0b013e3281e2c9e7 (Pubitemid 46934116)
90. Nadreau E., Baraboi E. D., Samson P., Blouin A., Hould F. S., Marceau P., Biron S., Richard D., Effects of the biliopancreatic diversion on energy balance in the rat. International Journal of Obesity 2006 30 3 419 429 2-s2.0-33644634243 10.1038/sj.ijo.0803166